Breast Neoplasms: all 12,820 studies
Page 115 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00674414Phase 2
- Hypertension in Breast Cancer Patients Receiving BevacizumabTerminatedNCT00674011
- Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast CancerSuspendedNCT00673829Phase 1
- Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 MutationCompletedNCT00673335Phase 3
- Cognitive-Behavioral Therapy for Chronic Insomnia After Breast Cancer TreatmentCompletedNCT00672217Not applicable
- Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical ScanningStatus unknownNCT00671385
- Studying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast CancerCompletedNCT00670878Phase 3
- Self-Care for Lymphedema in Patients With Breast CancerCompletedNCT00670644
- Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer PatientStatus unknownNCT00669773Phase 2
- A Safety and Efficacy Study of Bavituximab Plus Docetaxel in Patients With Advanced Breast CancerCompletedNCT00669591Phase 2
- Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast CancerCompletedNCT00669565Phase 2
- Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph NodesCompletedNCT00668616Phase 3
- Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsCompletedNCT00667641Phase 1
- Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or SertralineCompletedNCT00667121
- Menopausal Symptoms in Women With Breast Cancer or At High Risk of Breast Cancer Treated on Another Clinical TrialCompletedNCT00666913
- Compliance to a Hormone Therapy Regimen in Breast CancerCompletedNCT00666822
- Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast CancerCompletedNCT00666731
- A Couples Approach to Enhance Breast Cancer SurvivorshipCompletedNCT00665899Not applicable
- Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the BreastCompletedNCT00665782
- Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian CancerCompletedNCT00664781Phase 2
- Aerobic Exercise, Resistance Exercise, or Flexibility and Relaxation Training in Inactive Older Female Breast Cancer SurvivorsCompletedNCT00662103Not applicable
- A Multicentre Phase I-II Study to Investigate the Combination of Bendamustine With Weekly Paclitaxel as First or Second Line Therapy in Patients With Metastatic Breast CancerCompletedNCT00661739Phase 1
- A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine).CompletedNCT00661102Phase 3
- Retrospective Brazilian Study of Fulvestrant in Advanced Breast CancerCompletedNCT00660803
- Optimizing Body Composition & Health After Breast CancerCompletedNCT00659906Not applicable
- Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or LymphomaCompletedNCT00659568Phase 1
- Setup Variation in the Supraclavicular Lymph Nodes Treatment in Breast Cancer PatientsCompletedNCT00658281
- IRS Proteins and Trastuzumab ResistanceCompletedNCT00657345
- APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)TerminatedNCT00657137Phase 2
- Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and ProteomicsCompletedNCT00656604Not applicable
- Musculoskeletal Pain in Postmenopausal, Early Breast Cancer Patients Receiving Aromatase Inhibitor Therapy - A Pilot StudyCompletedNCT00653718
- Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by SurgeryTerminatedNCT00651976Early Phase 1
- T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantTerminatedNCT00651716
- Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast CancerCompletedNCT00650910Phase 1
- Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Mammography, Including Cost ComparisonsStatus unknownNCT00649337Not applicable
- A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast CancerCompletedNCT00649090Phase 4
- Positron Emission Tomography (PET) Using Hormone Receptor Ligands in Breast CancerCompletedNCT00647790
- Radiation Therapy During and After Lumpectomy in Treating Women With Stage I or Stage II Breast CancerCompletedNCT00647582Phase 2
- Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast CancerCompletedNCT00647218Not applicable
- Yunzhi as Dietary Supplement in Breast CancerStatus unknownNCT00647075Phase 4
- Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With AngiogenesisCompletedNCT00646555
- Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast CancerCompletedNCT00645866Phase 2
- Axillary Reverse Mapping for Invasive Carcinoma of the BreastCompletedNCT00645541Phase 1
- Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast CancerCompletedNCT00645177Phase 2
- Comparison of Paravertebral Block With General Anesthesia in Patients Undergoing Breast Cancer SurgeryCompletedNCT00645138Phase 3
- A Pilot Observational Study to Assess Changes in Biochemical Parameters of Ovarian Reserve With ChemotherapyCompletedNCT00644683
- Quality Of Life While Receiving FaslodexCompletedNCT00643513
- Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast CancerCompletedNCT00641303Not applicable
- Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast CancerCompletedNCT00640861Early Phase 1
- Changes in Cancer-related Cytokines After Participation in a Physical Activity Behavior Change Intervention (CICK Study)CompletedNCT00640666Not applicable
- Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast CancerCompletedNCT00639366Phase 3
- BREAST CANCER AND EXERCISECompletedNCT00639210Phase 3
- Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or MalignantCompletedNCT00639171
- Comparison of Laryngeal Mask Airway (LMA®) and Tracheal Tube in Modified Radical Mastectomy on Breast CancerCompletedNCT00638599Phase 4
- Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast CancerCompletedNCT00638391
- Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast CancerCompletedNCT00637897Phase 1
- Early Detection of Breast Cancer Using Tomosynthesis ImagingCompletedNCT00637598Not applicable
- A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast CancerCompletedNCT00637481Phase 1
- Trastuzumab Optimization Trial in Breast CancerStatus unknownNCT00637325Phase 3
- Ph II Early BC Pre-Surgical Biologic StudyCompletedNCT00637026Phase 2
- Axillary Sentinel Lymph Node Detection in Breast Cancers > 2 cmCompletedNCT00636467Phase 2
- Second Line Breast Cancer TrialCompletedNCT00635713Phase 3
- CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By SurgeryWithdrawnNCT00635245Phase 1
- IRESSA™ (Gefitinib) in Breast Cancer PatientsCompletedNCT00632723Phase 2
- Early Detection of Breast Cancer and Cervical Cancer in Women in IndiaStatus unknownNCT00632047Phase 2
- DAMES: Daughters And MothErS Against Breast CancerCompletedNCT00630591Not applicable
- Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast CancerCompletedNCT00629616Phase 2
- Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast CancerStatus unknownNCT00629278Phase 3
- Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) MalignancyTerminatedNCT00629187Phase 1
- Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC)CompletedNCT00629148Phase 2
- A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast CancerWithdrawnNCT00627627Phase 1/2
- Vibro-Acoustography Imaging in Diagnosing Breast Masses in Women With a Breast Mass or Breast CancerCompletedNCT00627614Not applicable
- Vibro-Acoustography Imaging in Finding Breast Microcalcifications and Lesions in WomenCompletedNCT00626119
- BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus BevacizumabTerminatedNCT00625898Phase 3
- Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast TumorsCompletedNCT00625417Not applicable
- Expressive Writing and Adjustment to Metastatic Breast CancerCompletedNCT00624156
- Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With AnastrozoleCompletedNCT00623519
- A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast CancerCompletedNCT00620594Phase 1
- To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single AgentTerminatedNCT00620100Phase 2
- GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast CancerCompletedNCT00617968Phase 2
- Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: FeasibilityCompletedNCT00617370Not applicable
- Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After LumpectomyCompletedNCT00616135Phase 4
- Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast CancerCompletedNCT00615940Phase 2
- Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast CancerCompletedNCT00615602Phase 3
- Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast CancerWithdrawnNCT00615524Phase 2
- Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast CancerCompletedNCT00614978Phase 1
- Healing Touch and Health-Related Quality of Life in Women With Breast Cancer Receiving Radiation TherapyCompletedNCT00612443Phase 2/3
- Studying the Effect of Freeze-Dried Table Grape Powder on Blood Estrogen Levels in Postmenopausal WomenCompletedNCT00611104
- Magnetic Resonance Imaging in Patients With Breast CancerCompletedNCT00610181
- A Study of Ispinesib in Metastatic Breast CancerTerminatedNCT00607841Phase 1
- A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast CancerTerminatedNCT00607438Phase 2
- Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer PatientsCompletedNCT00607295Phase 3
- PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast CancerCompletedNCT00605397Phase 1
- Neoadjuvant Endostatin and Chemotherapy for Breast CancerCompletedNCT00604435Phase 2
- Effect of Aromatase Inhibitors on Bones and GenesCompletedNCT00603967Not applicable
- Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the BreastCompletedNCT00602628Not applicable
- Multifunctional Magnetic Resonance Imaging in Predicting Breast Lesions in Women Undergoing Mastectomy for Breast CancerStatus unknownNCT00602316Not applicable
- Radiation Therapy in Treating Women Undergoing Lumpectomy for Stage I or Stage IIA Breast CancerCompletedNCT00602108Phase 2
- Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological CancerStatus unknownNCT00601406Not applicable
- Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBCCompletedNCT00601159Phase 2